Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000494437) titled 'The effect of a 6-month personalised lifestyle medicine on the change in the progression of Type 2 Diabetes' on May 21.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: Griffith University
Condition:
Type 2 Diabetes and Pre-diabetes
Type 2 Diabetes and Pre-diabetes
Metabolic and Endocrine - Diabetes
Intervention:
The intervention involves the participants following the recommendations from the Shae platform and Shae app for a period of 6 months. There will b...